BiotechTube

Clopidogrel

ApprovedUNKNOWN
0 watching 0 views this week๐Ÿ”ฅ Hot
84
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
โœ“
Phase 3
5
Approved
Indication / Disease

Coronary Heart Disease

Conditions

Coronary Heart Disease

Trial Timeline

Jan 1, 2017 โ†’ Dec 1, 2017

NCT ID
NCT03006835

About Clopidogrel

Clopidogrel is a approved stage product being developed by Shenzhen Salubris Pharmaceuticals for Coronary Heart Disease. The current trial status is unknown. This product is registered under clinical trial identifier NCT03006835. Target conditions include Coronary Heart Disease.

Hype Score Breakdown

Clinical
30
Activity
20
Company
9
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT03006835ApprovedUNKNOWN

Competing Products

20 competing products in Coronary Heart Disease

See all competitors
ProductCompanyStageHype Score
Rosuvastatin 40mg + PlaceboHeartFlowPre-clinical
18
EvolocumabHeartFlowApproved
80
High intensity lipid loweringHeartFlowPre-clinical
18
ExenatideEli LillyPhase 3
77
Clopidogrel treatment groupYuhanApproved
85
YH14659 + clopidogrel & aspirinYuhanPhase 1
33
high-dose rosuvastatin + low-dose rosuvastatin plus ezetimibeYuhanApproved
85
Sarpogrelate + Aspirin + Clopidogrel + Placebo (for Sarpogrelate)YuhanPhase 3
77
statins, ezetimibe + Combination therapyYuhanApproved
85
YH14659 + clopidogrel & aspirinYuhanPhase 1
33
Modification of Prasugrel based on a biological assay + prasugrel / clopidogrelDaiichi SankyoApproved
85
clopidogrel + prasugrelDaiichi SankyoPhase 1
33
PrasugrelDaiichi SankyoApproved
85
ADP receptor inhibitorsDaiichi SankyoPre-clinical
23
Pactimibe, CS-505Daiichi SankyoPhase 2
52
Prasugrel + ClopidogrelDaiichi SankyoPhase 2
52
prasugrel + clopidogrelDaiichi SankyoPhase 1
33
Prasugrel + ClopidogrelDaiichi SankyoApproved
85
Triple oral lipid lowering treatmentDaiichi SankyoPhase 3
77
Placebo + PrasugrelDaiichi SankyoPhase 3
77

Other Products from Shenzhen Salubris Pharmaceuticals

Allisartan Isoproxil Tablets 240mg or placebo + Allisartan Isoproxil Tablets 480mg or placebo + Allisartan Isoproxil Tablets 720mg or placeboApproved
84
Enarodustat 2mg + Enarodustat 3mg + Enarodustat 4mgApproved
84
SAL056 (56.5ฮผg) + AlendronatePhase 3
76
SAL-0951 + PlaceboPhase 3
76
SAL067 + Alogliptin + PlaceboPhase 3
76